Skip to content

Agrify Corporation RYM Finite Lived Intangible Assets Accumulated Impairment Amount

Finite Lived Intangible Assets Accumulated Impairment Amount at other companies

Pathward Financial, Inc. logo
Pathward Financial, Inc.CASH
$11.07M0.0%
MAG
MagneraMAGN
$0
PepsiCo logo
PepsiCoPEP
$1.93B+8.2%
Mondelez International logo
Mondelez InternationalMDLZ
$2.51B+8.4%
State Street logo
State StreetSTT
$3.16B+9.7%
Ametek logo
AmetekAME
$2.1B+17.2%

Other financials

Income statement

See full
Revenue$13.3M+2,370%
Gross profit$10.4M+11,452%
Operating income-$4.0M-9.0%
Net income$19.9M+1,325%
EPS (diluted)$1.33+260%

Balance sheet

See full
Cash & equivalents$33.3M+36.0%
Total debt$89.2M+695%
Total equity$36.6M+36.4%
Total assets$127.5M+180%

Cash flow

See full
Operating cash flow$1.0M+116%
CapEx$2.0K+100%
Free cash flow-$1.8M+15.5%

Valuation

See full
Market cap$54.76M+33.0%
Enterprise value$110.74M+43.3%
P/S1.8×

Profitability

See full
Gross margin68.3%
Operating margin-108.8%
Net margin-39%
FCF margin-244.9%+1,014pp

Returns & leverage

See full
Return on equity-36.9%
Debt / equity2.4×+2.0×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by Agrify Corporation in its filing.

Tagged under the XBRL concept agfy:FiniteLivedIntangibleAssetsAccumulatedImpairmentAmount.

The official record: Agrify Corporation’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agrify Corporation's finite lived intangible assets accumulated impairment amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agrify Corporation's finite lived intangible assets accumulated impairment amount?
Agrify Corporation (RYM) reported finite lived intangible assets accumulated impairment amount of $8.9M in Q4 2024.
What does finite lived intangible assets accumulated impairment amount mean?
This represents the total cumulative reduction in the carrying value of intangible assets with finite useful lives due to impairment charges. It serves as a critical indicator of historical overvaluation or declining economic utility of acquired assets like patents, licenses, or brand names.